Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Schütz
Detlew Labes
Martin J Wolfsegger

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 16, 2022
Critical Remarks on Reference-Scaled Average BioequivalenceHelmut Schütz, Detlew Labes, Martin J Wolfsegger
Pharmaceutical Research|August 3, 2016
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its ControlDetlew Labes, Helmut Schütz
The AAPS Journal|September 13, 2014
Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studiesHelmut Schütz, Detlew Labes, Anders Fuglsang
The AAPS Journal|December 10, 2014
Reference datasets for bioequivalence trials in a two-group parallel designAnders Fuglsang, Helmut Schütz, Detlew Labes
Pharmaceutical Statistics|October 16, 2020
Assessing goodness-of-fit for evaluation of dose-proportionalityMartin J Wolfsegger, Alexander Bauer, Detlew Labes, et al.
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
The AAPS Journal|February 9, 2020
Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding LimitsHelmut Schütz, Detlew Labes, Michael Tomashevskiy, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
The AAPS Journal|December 16, 2024
Rejoinder to the 'Letter to the Editor' on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"Helmut Schütz, Divan A Burger, Erik Cobo, et al.
The AAPS Journal|May 6, 2024
Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 16, 2022
Critical Remarks on Reference-Scaled Average BioequivalenceHelmut Schütz, Detlew Labes, Martin J Wolfsegger
Pharmaceutical Research|August 3, 2016
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its ControlDetlew Labes, Helmut Schütz
The AAPS Journal|September 13, 2014
Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studiesHelmut Schütz, Detlew Labes, Anders Fuglsang
The AAPS Journal|December 10, 2014
Reference datasets for bioequivalence trials in a two-group parallel designAnders Fuglsang, Helmut Schütz, Detlew Labes
Pharmaceutical Statistics|October 16, 2020
Assessing goodness-of-fit for evaluation of dose-proportionalityMartin J Wolfsegger, Alexander Bauer, Detlew Labes, et al.
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
The AAPS Journal|February 9, 2020
Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding LimitsHelmut Schütz, Detlew Labes, Michael Tomashevskiy, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
The AAPS Journal|December 16, 2024
Rejoinder to the 'Letter to the Editor' on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"Helmut Schütz, Divan A Burger, Erik Cobo, et al.
The AAPS Journal|May 6, 2024
Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
Pageof 4